Arginase inhibitor (investigational)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Arginase inhibitor (investigational), covering 2016-02-22 to 2016-02-22. Get the full timeline:
Most recent: Clinical Trial Update: Arginase Inhibition and Microvascular Endothelial Function in Type 2 Diabetes [Phase 1, Phase 2]